Study on dynamic characteristics’ change of hippocampal neuron reduced models caused by the Alzheimer’s disease

Abstract

In the paper, based on the electrophysiological experimental data, the Hippocampal neuron reduced model under the pathology condition of Alzheimer's disease (AD) has been built by modifying parameters' values. The reduced neuron model's dynamic characteristics under effect of AD are comparatively studied. Under direct current stimulation, compared with the normal neuron model, the AD neuron model's dynamic characteristics have obviously been changed. The neuron model under the AD condition undergoes supercritical Andronov-Hopf bifurcation from the rest state to the continuous discharge state. It is different from the neuron model under the normal condition, which undergoes saddle-node bifurcation. So, the neuron model changes into a resonator with monostable state from an integrator with bistable state under AD's action. The research reveals the neuron model's dynamic characteristics' changing under effect of AD, and provides some theoretic basis for AD research by neurodynamics theory. ARTICLE HISTORY

Electroacupuncture ameliorate learning and memory by improving N-acetylaspartate and glutamate metabolism in APP/PS1 mice

“…With the world population grows, the incidence of AD and the cost of AD are growing at an ever-increasing rate, and it has become a social issue [ 1 ]. It is generally agreed that the neuropathologic hallmarks of AD can be summarized as extracellular deposits of amyloid-β protein (Aβ), intracellular neurofibrillary tangles (NFTs) and neuronal loss in the brain [ 2 , 3 ]. The early accumulation of Aβ may lead a series of downstream events including neuronal degeneration, then evolved into volume atrophy and cognitive functional damage of the corresponding brain area gradually.…”

Electroacupuncture at ST 36 ameliorates cognitive impairment and beta-amyloid pathology by inhibiting NLRP3 inflammasome activation in an Alzheimer’s disease animal model

“…The brains of AD patients are characterized by an accumulation of extracellular beta-amyloid (Aβ) plaques and the deposition of intracellular neurofibrillary tangles (NFTs) [ 2 ]. Although the pathology of AD has been characterized, the mechanisms of neuronal loss and cognitive impairment in AD remain elusive [ 3 , 4 ]. Most therapeutic agents used to clinically treat AD target Aβ and NFTs but do not stop or reverse disease progression.…”